Sort
30,917 grants matching “tumor microenvironment”
Enhancing the efficacy of Radiation Therapy for brainstem glioma by targeting ATM
$266,898Zachary Reitman · Duke University · K08 · FY2023 · CA
Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma
$266,884Robert Wi Chen · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA
Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)
$266,856Robert Loberg · University Of Michigan At Ann Arbor · P50 · FY2011 · CA
New 3D tumor models to rapidly test drugs for brain cancer therapy
$266,843Miqin Zhang · University Of Washington · R01 · FY2013 · CA
Gene expression programs of lactic acidosis in human cancers
$266,760Jen-Tsan Ashley Chi · Duke University · R01 · FY2009 · CA
Gene expression programs of lactic acidosis in human cancers
$266,760Jen-Tsan Ashley Chi · Duke University · R01 · FY2008 · CA
Gene expression programs of lactic acidosis in human cancers
$266,760Jen-Tsan Ashley Chi · Duke University · R01 · FY2007 · CA
Gene expression programs of lactic acidosis in human cancers
$266,760Jen-Tsan Ashley Chi · Duke University · R01 · FY2010 · CA
Core B: Biospecimen Core
$266,752Ryan C Fields · Washington University · P50 · FY2025 · CA
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIs
$266,679Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2007 · CA
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIs
$266,679Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2010 · CA
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIs
$266,679Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2009 · CA
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIs
$266,679Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2008 · CA
Microfluidic approach for the development of a three-dimensional bone marrow micr
$266,662Jenny Zilberberg · Hackensack University Medical Center · R21 · FY2015 · CA
Manipulation of Tumor Specific Immunity
$266,640Hans Schreiber · University Of Chicago · R01 · FY2010 · CA
Mechanisms of mucosal immune evasion in high grade cervical dysplasia
$266,635Cornelia L Trimble · Johns Hopkins University · R01 · FY2012 · CA
Core B â Human Biospecimen and Advanced Sequencing Core
$266,598Leonidas G Koniaris · Medical University Of South Carolina · P01 · FY2021 · CA
Planning and Evaluation Core
$266,501Jefferey L Burgess · University Of Arizona · U54 · FY2020 · CA
Planning and Evaluation Core
$266,501Jefferey L Burgess · University Of Arizona · U54 · FY2021 · CA
Planning and Evaluation Core
$266,495Jefferey L Burgess · University Of Arizona · U54 · FY2019 · CA
Multiscale Stereolithogrphic Bioprinting of Stage-Matching Vascularized Tumor Models
$266,454Y. Shrike Zhang · Brigham And Women'S Hospital · R21 · FY2020 · EB
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
$266,417Kristine Glunde · Johns Hopkins University · R01 · FY2021 · CA
Control of Dendritic Cell Generation and Function by Tumor
$266,360University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC
$266,292Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
RecqL4, chromosome instability and cancer predisposition
$266,285Guangbin Luo · Case Western Reserve University · R01 · FY2007 · CA